Brief: Unicycive Therapeutics Receives Confirmatory Guidance On Renazorb Regulatory Pathway
29/11/2021 12:26
Nov 29 (Reuters) - Unicycive Therapeutics Inc UNCY.O :
* UNICYCIVE THERAPEUTICS RECEIVES CONFIRMATORY GUIDANCE ON
RENAZORB REGULATORY PATHWAY
* UNICYCIVE THERAPEUTICS INC - ON-TRACK TO SUBMIT NEW DRUG
APPLICATION IN Q4 2022
Source text for Eikon: ID:nPn5M4PgSa
Further company coverage: UNCY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unicycive Therapeutics
See all newsBrief: Unicycive Therapeutics Appoints Meredith Manning To Board Of Directors
Brief: Unicycive Therapeutics Announces Resubmission Of New Drug Application For Oxylanthanum Carbonate
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
Unicycive rises on narrower quarterly loss